Virtual Roundtable: Mobilizing Molecular Diagnostics for the Next Pandemic

The COVID-19 pandemic is well in the rear-view mirror, but the unprecedented challenges to public health systems and subsequent early failings won’t soon be forgotten. In particular, molecular testing, the most accurate method of obtaining a reliable diagnosis, was often hampered during the pandemic as diagnostic testing laboratories, manufacturers, and regulators struggled to mobilize testing and keep up with demand.

Join Emmanuel Agogo, FIND’s Director, Pandemic Threats Programme and three other experts in this roundtable webinar.

Register for the webinar

As public health officials contemplate the next potential infectious disease pathogen — caused by a hypothetical, unknown ‘Disease X’ as adopted by the World Health Organization — stakeholders must consider lessons learned from COVID-19 and look to future molecular testing technologies and strategies to ensure that the world is ready. In particular, special attention must be paid to lower-resource areas of the world to ensure that molecular testing is expedient and equitable in the next pandemic.

Speakers:

• Amesh Adalja, Senior Scholar at the Johns Hopkins Center for Health Security, an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health, and an Affiliate of the Johns Hopkins Center for Global Health; 
• Emmanuel Agogo, Director, Pandemic Threats Programme at FIND;
• Claudia Denkinger, Professor of Medicine/Infectious Diseases and Director of the Department of Infectious Diseases and Tropical Medicine at University Hospital Heidelberg;
• Jennifer Nuzzo, Director of the Pandemic Center, and Professor of Epidemiology at the Brown University School of Public Health.